U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730294) titled 'Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery' on July 17.
Brief Summary: This study is testing whether oxytocin can help lessen pain by changing how people process emotions and social experiences. The goal is to better understand how the brain links emotions, relationships, and pain, and whether this connection can be used to improve pain treatment.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Pain
Pituitary Surgery
Intervention:
DRUG: Oxytocin (Low dose)
The dosage for low -dose intranasal oxytocin is set at 6 International Units (IU) per day, divided in...